ArticleCurrent neuropharmacology2023

mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data.

Roberta Celli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.